Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
April, 2026
April 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
27282930  

Caplacizumab

A Novel Genetic Mechanism of Caplacizumab Resistance in iTTP - JTH
Apr 11, 2026, 12:26 | Science
A Novel Genetic Mechanism of Caplacizumab Resistance in iTTP - JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article…
Frank Nocken: FDA Approves Caplacizumab Therapy for Pediatric Acquired TTP
Apr 6, 2026, 13:51 | Voices
Frank Nocken: FDA Approves Caplacizumab Therapy for Pediatric Acquired TTP
Frank Nocken, Independent Consultant for Scientific Innovation Management, shared a post on LinkedIn: "'The FDA…
Rens De Groot: The 1st Reported Case of Caplacizumab Resistance
Feb 20, 2026, 09:04 | Science
Rens De Groot: The 1st Reported Case of Caplacizumab Resistance
Rens De Groot, Principal Research Fellow at University College London, shared on LinkedIn about a recent…
Wolfgang Miesbach: Caplacizumab as Frontline Therapy for iTTP
Dec 20, 2025, 12:07 | Science
Wolfgang Miesbach: Caplacizumab as Frontline Therapy for iTTP
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn: “Caplacizumab as Frontline Therapy…
Sarah Elkourashy Presents Insights on Caplacizumab for TTP at ASH25
Dec 19, 2025, 10:51 | Insight
Sarah Elkourashy Presents Insights on Caplacizumab for TTP at ASH25
Sarah Elkourashy, Consultant in Clinical Hematology and BMT at Hamad Medical Corporation, Assistant professor of…
Wolfgang Miesbach on Linus Völker's Presentation of Caplacizumab as Frontline Therapy for iTTP
Dec 17, 2025, 06:28 | Insight
Wolfgang Miesbach on Linus Völker's Presentation of Caplacizumab as Frontline Therapy for iTTP
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn: ''Caplacizumab as Frontline…
Silvia Escribano Serrat Explores A Potential Role of EASIX as a Predictor of Refractoriness and Mortality in iTTP
Nov 17, 2025, 17:26 | Science
Silvia Escribano Serrat Explores A Potential Role of EASIX as a Predictor of Refractoriness and Mortality in iTTP
Silvia Escribano Serrat, Research Fellow at Memorial Sloan Kettering Cancer Center, shared on LinkedIn: ''I…
Flora Peyvandi on Caplacizumab: Which VWF Assays Truly Measure Treatment Effectiveness?
Sep 10, 2025, 08:20 | Science
Flora Peyvandi on Caplacizumab: Which VWF Assays Truly Measure Treatment Effectiveness?
Flora Peyvandi, Professor of Internal Medicine-Hemostasis and Thrombosis Unit, University of Milan, former President of…
All: 8 Posts: 1 - 100
NewsFeed